Bristol-Myers Squibb | Fremdkapital



Loan Capital Veränderung Datum
AbbVie USD 60.34B 1.83B 2024-12
Abbott USD 12.74B 111M 2025-03
ALKERMES USD 0 0 2025-03
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
J&J USD 38.36B 7.7B 2025-03
Medtronic USD 25.64B 1.66B 2025-04
Merck USD 33.48B 978M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Novo Nordisk 96.31B 44.86B 2025-03
Perrigo USD 3.58B 730.9M 2024-12
Pfizer USD 57.64B 234M 2025-03
Prestige Brands USD 1.01B 16.93M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
Sanofi 11.79B 712M 2024-12
United Therapeutics USD 0 0 2025-03
Zoetis USD 5.23B 7M 2025-03



Bristol-Myers Squibb Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.